世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4499 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ペプチドベース胃腸障害治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（テデュグルチド、リナクロチド、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ペプチドベース胃腸障害治療薬の市場動向 ・企業の競争状況、市場シェア ・ペプチドベース胃腸障害治療薬の種類別市場規模（テデュグルチド、リナクロチド、その他） ・ペプチドベース胃腸障害治療薬の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・ペプチドベース胃腸障害治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ペプチドベース胃腸障害治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペプチドベース胃腸障害治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペプチドベース胃腸障害治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペプチドベース胃腸障害治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda、Ironwood Pharmaceuticals、Astellas Pharma、Allergan、Takeda Pharmaceutical） ・結論

Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.

Market Analysis and Insights: Global Peptide Based Gastrointestinal Disorders Therapeutics Market
The global Peptide Based Gastrointestinal Disorders Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Based Gastrointestinal Disorders Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide Based Gastrointestinal Disorders Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide Based Gastrointestinal Disorders Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide Based Gastrointestinal Disorders Therapeutics market.

Global Peptide Based Gastrointestinal Disorders Therapeutics Scope and Market Size
Peptide Based Gastrointestinal Disorders Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Based Gastrointestinal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Teduglutide
Linaclotide
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda
Ironwood Pharmaceuticals
Astellas Pharma
Allergan
Takeda Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Teduglutide
1.2.3 Linaclotide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Perspective (2016-2027)
2.2 Peptide Based Gastrointestinal Disorders Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Peptide Based Gastrointestinal Disorders Therapeutics Industry Dynamic
2.3.1 Peptide Based Gastrointestinal Disorders Therapeutics Market Trends
2.3.2 Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
2.3.3 Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
2.3.4 Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide Based Gastrointestinal Disorders Therapeutics Revenue
3.4 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2020
3.5 Peptide Based Gastrointestinal Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Type
4.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2022-2027)

5 Peptide Based Gastrointestinal Disorders Therapeutics Breakdown Data by Application
5.1 Global Peptide Based Gastrointestinal Disorders Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2016-2027)
6.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
6.2.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2027)
6.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
6.3.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2027)
6.4 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
6.4.1 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2016-2027)
7.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
7.2.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2027)
7.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
7.3.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2027)
7.4 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
7.4.1 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
8.2.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
8.3.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region
8.4.1 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2016-2027)
9.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
9.2.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
9.3.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
9.4.1 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type
10.2.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application
10.3.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country
10.4.1 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.1.4 Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 Ironwood Pharmaceuticals
11.2.1 Ironwood Pharmaceuticals Company Details
11.2.2 Ironwood Pharmaceuticals Business Overview
11.2.3 Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.2.4 Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
11.2.5 Ironwood Pharmaceuticals Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Details
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.3.4 Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
11.3.5 Astellas Pharma Recent Development
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.4.4 Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
11.4.5 Allergan Recent Development
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Details
11.5.2 Takeda Pharmaceutical Business Overview
11.5.3 Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
11.5.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Teduglutide
Table 3. Key Players of Linaclotide
Table 4. Key Players of Others
Table 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2022-2027)
Table 11. Peptide Based Gastrointestinal Disorders Therapeutics Market Trends
Table 12. Peptide Based Gastrointestinal Disorders Therapeutics Market Drivers
Table 13. Peptide Based Gastrointestinal Disorders Therapeutics Market Challenges
Table 14. Peptide Based Gastrointestinal Disorders Therapeutics Market Restraints
Table 15. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2020)
Table 18. Ranking of Global Top Peptide Based Gastrointestinal Disorders Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Based Gastrointestinal Disorders Therapeutics Product Solution and Service
Table 22. Date of Enter into Peptide Based Gastrointestinal Disorders Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Peptide Based Gastrointestinal Disorders Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takeda Company Details
Table 63. Takeda Business Overview
Table 64. Takeda Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 65. Takeda Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Ironwood Pharmaceuticals Company Details
Table 68. Ironwood Pharmaceuticals Business Overview
Table 69. Ironwood Pharmaceuticals Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 70. Ironwood Pharmaceuticals Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Ironwood Pharmaceuticals Recent Development
Table 72. Astellas Pharma Company Details
Table 73. Astellas Pharma Business Overview
Table 74. Astellas Pharma Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 75. Astellas Pharma Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Astellas Pharma Recent Development
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 80. Allergan Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Allergan Recent Development
Table 82. Takeda Pharmaceutical Company Details
Table 83. Takeda Pharmaceutical Business Overview
Table 84. Takeda Pharmaceutical Peptide Based Gastrointestinal Disorders Therapeutics Product
Table 85. Takeda Pharmaceutical Revenue in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Takeda Pharmaceutical Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Teduglutide Features
Figure 3. Linaclotide Features
Figure 4. Others Features
Figure 5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Peptide Based Gastrointestinal Disorders Therapeutics Report Years Considered
Figure 10. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Players in 2020
Figure 15. Global Top Peptide Based Gastrointestinal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Based Gastrointestinal Disorders Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Peptide Based Gastrointestinal Disorders Therapeutics Revenue in 2020
Figure 17. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Peptide Based Gastrointestinal Disorders Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Region (2016-2027)
Figure 39. China Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Peptide Based Gastrointestinal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Peptide Based Gastrointestinal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Takeda Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
Figure 59. Ironwood Pharmaceuticals Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
Figure 60. Astellas Pharma Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Peptide Based Gastrointestinal Disorders Therapeutics Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---